JA

Joseph A. Yanchik III

Venture Partner at Apple Tree Partners

Cambridge, Massachusetts

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Mergers
Start-ups
Lifesciences
Oncology
Pharmaceutical Industry
Strategic Planning
Drug Development
Drug Discovery
Biopharmaceuticals
Strategy
Corporate Development
Venture Capital
Clinical Development
Licensing
Commercialization
Technology Transfer
Molecular Biology
Mergers & Acquisitions
Life Sciences

Education

Investments

Red Queen Therapeutics

Series A

Total Funding: $55M

Marengo Therapeutics

Seed

Total Funding: $80M

Replicate Bioscience

Series A

Total Funding: $40M

Aulos Bioscience

Series A

Total Funding: $60M

Eledon Pharmaceuticals

Series B

Total Funding: $90M

Work Experience

Apple Tree Partners

2020

  • Venture Partner

    2020

Five Islands Venture Advisors

2019 - 2020

  • Owner

    2019 - 2020

Aileron Therapeutics

2005 - 2018

  • Co-Founder, CEO & Director

    2005 - 2018

Tokai Pharmaceuticals, Inc.

2005 - 2017

  • Board of Directors

    2005 - 2017

  • Co-Founder & CEO

    2005 - 2008

Apple Tree Partners

2005 - 2009

  • Venture Partner

    2005 - 2009

Mendel Biotechnology, Inc.

2004 - 2005

  • Vice President, Corporate Development and Legal Affairs

    2004 - 2005

Poetic Genetics, Inc.

2002 - 2004

  • Chief Financial Officer

    2002 - 2004

Venture Law Group

1997 - 1999

  • Attorney

    1997 - 1999

Cahill Gordon & Reindel

1993 - 1997

  • Attorney

    1993 - 1997